蘋果據報因晶片短缺削減iPhone13系列年內產量最多1,000萬部
《彭博通訊社》報道,蘋果(AAPL.US)將削減iPhone13系列產量最多1,000萬部,受全球晶片短缺影響.。公司原預計今年底前生產9,000萬部該系列手機。
報道指蘋果已通知包括博通及德州儀器等生產商,因晶片供應問題削減產量。蘋果七月預計收入增長將因晶片短缺拖累而放緩,並已影響個人電腦Mac及平板電腦iPad產量。德州儀器早前亦預計晶片短缺影響收入.。
蘋果股價在延長交易時段跌1.3%,報139.63美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.